
The FDA has approved its first two therapies for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM), …

Health Secretary Matt Hancock has said he would not rule out ‘compulsory vaccination,’ as he argued that those spreading anti-vaccine …

GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …

This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …

The founder of opioid drugmaker Insys Therapeutics has been found guilty of bribing doctors in order to persuade them to …

The risk of transmitting HIV through gay sex when the infected partner’s HIV load has been fully supressed by antiretroviral …

Sanofi has announced that the FDA has granted authorisation to its tetravalent vaccine Dengvaxia for prevention of dengue disease originating …

Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, both of which are currently …

A hormone-based therapy might improve social function in people with autism, according to the results of two separate clinical trials. …

The FDA has approved AbbVie’s Mavyret tables (glecaprevir/pibrentasvir) as a treatment for hepatitis C (HCV) in children aged 12 to 17 …

Biopharma firm Nabriva Therapeutics has revealed that its antibiotic Contepo (fosfomycin) has been rejected for review by the FDA as …

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …

GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …

President Donald Trump has said he will not accept money from pharmaceutical companies in the run up to the 2020 …